Menkes Disease (Kinky Hair Disease) – Drugs In Development, 2024
Powered by ![]()
Unlock hidden opportunities in the Pharmaceuticals industry
Empower your strategies with our Menkes Disease (Kinky Hair Disease) – Drugs In Development, 2024 report and make more profitable business decisions.
Menkes disease, or kinky hair disease, is a progressive disorder that affects copper metabolism in the body. It is caused by mutations in the ATP7A gene, which regulates copper transport. Symptoms include coarse, kinky hair, failure to grow and thrive, neurological degeneration, and nervous system deterioration. It can be diagnosed by low levels of serum copper and ceruloplasmin. There is no cure for Menkes disease, but treatment with parenteral copper histidinate (CuHis) can increase survival.
The Menkes Disease (Kinky Hair Disease) drugs in development market research report provide comprehensive information on the therapeutics under development for Menkes Disease (Kinky Hair Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action and product description of the therapeutics, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Menkes Disease (Kinky Hair Disease) and features dormant and discontinued products.
Note:
* This is an “on-demand” report and will be delivered within 2 business days (excluding weekends and holidays) of the purchase.
* Certain sections in the report may be removed or altered based on the availability and relevance of data.
| Quick View – Menkes Disease (Kinky Hair Disease) | Key Targets |
|
|
| Key Mechanisms of Action |
|
||
| Key Routes of Administration |
|
||
| Key Molecule Types |
|
||
| Major Companies |
|
||
Scope
- Therapeutics in Development: Covering 5 molecules, with 5 developed by companies and the rest by universities/institutes.
- Analysis Parameters: Offering insights by stage of development, drug target, MoA, RoA, and molecule type for a comprehensive overview.
- Pharmacological Insights: Understand the descriptive pharmacological action of therapeutics.
- Development History: Access the complete research and development history.
- Latest News and Press Releases: Stay updated with the latest developments through comprehensive news coverage.
Reasons to Buy
- Holistic insights: Understand the broad spectrum of Menkes Disease (Kinky Hair Disease) therapeutics, aiding strategic decision-making with insights into stages, targets, MoA, RoA and molecule types.
- Pipeline Exploration: Explore the detailed Menkes Disease (Kinky Hair Disease) pipeline, offering nuanced analysis of drug targets, mechanisms of action and routes of administration for varied decision-making.
- Comprehensive R&D: Access thorough R&D histories, providing a comprehensive understanding of Menkes Disease (Kinky Hair Disease) treatments for adaptable decision-making.
- Save valuable hours: Identify key players steering innovation in therapeutics, enabling strategic partnerships.
Key Players
Collaborative Medicinal Development LLCCyprium Therapeutics Inc
Engrail Therapeutics Inc
Lantu Biopharma
Sentynl Therapeutics Inc
Table of Contents
Table
Figures
Frequently asked questions
Related reports
View more Menkes Disease (Kinky Hair Disease) reports